OACC Oaktree Acquisition Corp. III Life Sciences logo

OACC Oaktree Acquisition Corp. III Life Sciences

Financial Services
$10.70+0.00%ClosedMarket Cap: $263.0M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

35.75

PEG

P/B

1.05

P/S

0.00

EV/EBITDA

-216.80

DCF Value

FCF Yield

-0.2%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

3.6%

ROA

3.4%

ROIC

-0.6%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$0.00$1.4M$
Q4 null$0.00$1.8M$
FY null$0.00$7.3M$
Q3 null$0.00$2.0M$

Trading Activity

Insider Trades

View All
Martinez George Arthur
SellWed Oct 29
BERRY DAVID A
SellWed Oct 22
Sweeney Thomas
SellMon Jun 16
Oaktree Acquisition Holdings III LS, LLC10 percent owner
SellThu Oct 31
Oaktree Acquisition Holdings III LS, LLC10 percent owner
SellThu Oct 31

Company Info

Sector

Financial Services

Industry

Shell Companies

Country

US

Exchange

Beta

-0.04

Oaktree Acquisition Corp. III Life Sciences focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.

Peers